Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
30 Day Daily Return
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Month-End Total Returns as of 10/31/2024
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -5.65% | -9.72% | 20.07% | 6.26% | 45.93% | -12.62% | 4.32% | 0.00% | 15.45% | 04/07/2010 |
| BIB NAV | -5.52% | -9.53% | 20.43% | 6.34% | 46.24% | -12.56% | 4.33% | 0.03% | 15.46% | 04/07/2010 |
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -5.12% | 7.86% | 11.58% | 12.62% | 34.03% | -12.17% | 8.62% | 2.15% | 16.01% | 04/07/2010 |
| BIB NAV | -5.08% | 7.92% | 11.63% | 12.55% | 33.84% | -12.12% | 8.61% | 2.17% | 16.01% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.14%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 11/21/2024- NAV $55.20
- NAV Change $+0.74
- Market Price $55.10
- Market Price Change $+0.79
- Trading Volume (M) 11,255
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.14%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 11/21/2024- NAV $55.20
- NAV Change $+0.74
- Market Price $55.10
- Market Price Change $+0.79
- Trading Volume (M) 11,255
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.
Exposures
Index as of 9/30/2024
Holdings
as of 11/21/2024
| Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
|---|---|---|---|---|---|---|
| 42.12% | -- | NASDAQ BIO INDEX SWAP BNP PARIBAS | 30,691,863 | -- | 6,873 | -- |
| 30.19% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 22,001,863 | -- | 4,927 | -- |
| 29.60% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 21,568,703 | -- | 4,830 | -- |
| 8.10% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,899,018 | -- | 1,321 | -- |
| 7.36% | GILD | GILEAD SCIENCES INC | -- | $5,362,890.72 | 59,747 | 2369174 |
| 6.38% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 4,648,658 | -- | 1,041 | -- |
| 5.88% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $4,287,522.40 | 9,520 | 2931034 |
| 5.62% | AMGN | AMGEN INC | -- | $4,098,316.30 | 14,137 | 2023607 |
| 5.43% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 3,956,495 | -- | 886 | -- |
| 4.19% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,049,984 | -- | 683 | -- |
| 4.07% | REGN | REGENERON PHARMACEUTICALS | -- | $2,967,577.00 | 3,986 | 2730190 |
| 2.94% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,141,400.24 | 33,324 | 2989044 |
| 2.49% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,812,992.80 | 7,346 | B00FWN1 |
| 1.81% | BIIB | BIOGEN INC | -- | $1,316,539.32 | 8,332 | 2455965 |
| 1.71% | ILMN | ILLUMINA INC | -- | $1,248,937.83 | 9,117 | 2613990 |
| 1.50% | ARGX | ARGENX SE - ADR | -- | $1,096,211.38 | 1,837 | BDVLM39 |
| 1.28% | UTHR | UNITED THERAPEUTICS CORP | -- | $935,298.56 | 2,546 | 2430412 |
| 1.24% | VTRS | VIATRIS INC | -- | $904,975.00 | 68,300 | BMWS3X9 |
| 1.15% | MRNA | MODERNA INC | -- | $841,423.50 | 21,998 | BGSXTS3 |
| 1.10% | SNY | SANOFI-ADR | -- | $802,705.40 | 16,730 | 2964557 |
| 1.06% | INCY | INCYTE CORP | -- | $775,697.80 | 11,020 | 2471950 |
| 1.05% | SMMT | SUMMIT THERAPEUTICS INC | -- | $763,656.36 | 41,458 | BMTVQS7 |
| 1.00% | INSM | INSMED INC | -- | $725,847.54 | 9,834 | 2614487 |
| 0.99% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $722,375.00 | 5,779 | 2623911 |
| 0.95% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $691,351.20 | 10,896 | 2437071 |
| 0.93% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $676,922.40 | 25,641 | BMVP7Y0 |
| 0.83% | BNTX | BIONTECH SE-ADR | -- | $607,170.30 | 5,610 | BK6H543 |
| 0.83% | MEDP | MEDPACE HOLDINGS INC | -- | $607,072.32 | 1,776 | BDCBC61 |
| 0.83% | SRPT | SAREPTA THERAPEUTICS INC | -- | $603,219.50 | 5,459 | B8DPDT7 |
| 0.78% | EXEL | EXELIXIS INC | -- | $568,634.58 | 16,326 | 2576941 |
| 0.77% | PCVX | VAXCYTE INC | -- | $564,635.32 | 6,388 | BKPVGH6 |
| 0.74% | RVMD | REVOLUTION MEDICINES INC | -- | $542,760.02 | 9,559 | BL71K91 |
| 0.71% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $516,630.70 | 6,046 | BHCB0P4 |
| 0.69% | ROIV | ROIVANT SCIENCES LTD | -- | $500,186.94 | 42,317 | BMW4NZ9 |
| 0.67% | BGNE | BEIGENE LTD-ADR | -- | $491,847.68 | 2,528 | BYYWPW6 |
| 0.61% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $442,103.40 | 3,534 | B4Q5ZN4 |
| 0.56% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $407,928.36 | 1,239 | BD59BS7 |
| 0.56% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $406,674.24 | 3,316 | BV9G6B8 |
| 0.48% | BPMC | BLUEPRINT MEDICINES CORP | -- | $350,440.74 | 3,627 | BWY52P3 |
| 0.45% | HALO | HALOZYME THERAPEUTICS INC | -- | $331,279.30 | 7,249 | 2975098 |
| 0.44% | CYTK | CYTOKINETICS INC | -- | $320,962.11 | 6,733 | BBBSBJ5 |
| 0.43% | NUVL | NUVALENT INC-A | -- | $314,911.08 | 3,396 | BMVBZD3 |
| 0.41% | KRYS | KRYSTAL BIOTECH INC | -- | $299,502.47 | 1,643 | BD6JX35 |
| 0.39% | RNA | AVIDITY BIOSCIENCES INC | -- | $285,194.56 | 6,701 | BMWHPY1 |
| 0.39% | ADMA | ADMA BIOLOGICS INC | -- | $284,120.70 | 13,339 | B9NSBM2 |
| 0.39% | IONS | IONIS PHARMACEUTICALS INC | -- | $283,975.98 | 8,367 | BDJ0LS6 |
| 0.37% | AXSM | AXSOME THERAPEUTICS INC | -- | $269,727.93 | 2,747 | BYZR4X4 |
| 0.37% | ACLX | ARCELLX INC | -- | $268,375.94 | 3,077 | BPCJ1Q2 |
| 0.36% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $261,197.40 | 4,580 | BDD19F8 |
| 0.36% | ALKS | ALKERMES PLC | -- | $261,072.50 | 9,425 | B3P6D26 |
| 0.34% | BBIO | BRIDGEBIO PHARMA INC | -- | $250,085.64 | 10,761 | BK1KWG8 |
| 0.33% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $242,755.50 | 5,275 | BJ62Z18 |
| 0.31% | CRSP | CRISPR THERAPEUTICS AG | -- | $225,571.17 | 4,873 | BDHF4K6 |
| 0.31% | IMVT | IMMUNOVANT INC | -- | $222,325.58 | 8,377 | BJRFSB7 |
| 0.30% | GH | GUARDANT HEALTH INC | -- | $217,975.28 | 7,036 | BFXC911 |
| 0.28% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $206,486.94 | 3,498 | BF2YWG4 |
| 0.28% | IBRX | IMMUNITYBIO INC | -- | $200,700.14 | 39,861 | BNSP0B8 |
| 0.27% | DNLI | DENALI THERAPEUTICS INC | -- | $198,434.46 | 8,193 | BD2B4V0 |
| 0.27% | APLS | APELLIS PHARMACEUTICALS INC | -- | $193,389.75 | 6,969 | BYTQ6X1 |
| 0.26% | PTCT | PTC THERAPEUTICS INC | -- | $188,801.78 | 4,402 | B17VCN9 |
| 0.25% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $185,791.50 | 4,674 | BMX9K07 |
| 0.25% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $180,838.24 | 3,256 | BCBVTX1 |
| 0.24% | MRUS | MERUS NV | -- | $173,206.28 | 3,905 | BZBY005 |
| 0.24% | XENE | XENON PHARMACEUTICALS INC | -- | $172,612.60 | 4,337 | BRJ3GY4 |
| 0.24% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $171,636.66 | 5,367 | BKY5JZ8 |
| 0.23% | VCYT | VERACYTE INC | -- | $171,141.30 | 4,395 | BFTWZY0 |
| 0.23% | DYN | DYNE THERAPEUTICS INC | -- | $170,888.04 | 5,748 | BN15WD1 |
| 0.22% | FOLD | AMICUS THERAPEUTICS INC | -- | $161,196.00 | 16,968 | B19FQ48 |
| 0.22% | KYMR | KYMERA THERAPEUTICS INC | -- | $160,856.47 | 3,697 | BMPRZV5 |
| 0.22% | VCEL | VERICEL CORP | -- | $158,844.71 | 2,801 | BSBMN89 |
| 0.21% | VRNA | VERONA PHARMA PLC - ADR | -- | $156,361.80 | 4,130 | BYWPZK5 |
| 0.21% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $154,311.30 | 4,251 | BGMGM89 |
| 0.21% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $153,596.74 | 9,493 | 2713317 |
| 0.20% | VERA | VERA THERAPEUTICS INC | -- | $147,580.14 | 3,138 | BL55460 |
| 0.20% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $143,120.56 | 17,369 | BF0DMK7 |
| 0.19% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $140,360.50 | 3,370 | BDCBCD8 |
| 0.19% | TWST | TWIST BIOSCIENCE CORP | -- | $139,769.30 | 3,355 | BGKG6G7 |
| 0.19% | JANX | JANUX THERAPEUTICS INC | -- | $138,849.00 | 2,986 | BMFX8Y7 |
| 0.19% | GERN | GERON CORP | -- | $138,665.88 | 34,494 | 2370381 |
| 0.18% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $130,080.48 | 7,116 | BYQBFJ8 |
| 0.18% | IDYA | IDEAYA BIOSCIENCES INC | -- | $128,451.40 | 4,829 | BK0VHF6 |
| 0.17% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $124,160.85 | 2,787 | BNFWZS4 |
| 0.17% | AKRO | AKERO THERAPEUTICS INC | -- | $123,988.80 | 3,974 | BK7Y2V9 |
| 0.17% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $122,148.60 | 4,580 | BFZQ0L8 |
| 0.17% | LGND | LIGAND PHARMACEUTICALS | -- | $121,911.30 | 1,046 | 2501578 |
| 0.16% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $118,613.44 | 2,728 | BJDX8Y8 |
| 0.16% | KROS | KEROS THERAPEUTICS INC | -- | $115,648.32 | 2,148 | BM7V485 |
| 0.16% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $112,976.28 | 3,154 | B72ZBG4 |
| 0.15% | BEAM | BEAM THERAPEUTICS INC | -- | $111,250.44 | 4,718 | BK6L288 |
| 0.15% | APGE | APOGEE THERAPEUTICS INC | -- | $110,407.36 | 2,576 | BM9HHL5 |
| 0.15% | MNKD | MANNKIND CORP | -- | $108,585.30 | 15,737 | BF081J4 |
| 0.15% | IRON | DISC MEDICINE INC | -- | $108,149.02 | 1,703 | BMGJZJ8 |
| 0.15% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $108,097.19 | 3,253 | BKSGZN7 |
| 0.15% | NVCR | NOVOCURE LTD | -- | $105,855.46 | 6,194 | BYSS4X4 |
| 0.14% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $103,172.20 | 17,943 | BM9FJ13 |
| 0.14% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $102,641.00 | 3,410 | BQS9486 |
| 0.14% | WVE | WAVE LIFE SCIENCES LTD | -- | $102,372.90 | 7,134 | BYZG9R0 |
| 0.14% | TARS | TARSUS PHARMACEUTICALS INC | -- | $100,966.40 | 2,176 | BMH5RL1 |
| 0.14% | FTRE | FORTREA HOLDINGS INC | -- | $99,957.00 | 5,126 | BRXYZ57 |
| 0.14% | ARVN | ARVINAS INC | -- | $98,606.97 | 3,927 | BDZ30Q0 |
| 0.13% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $92,638.20 | 7,495 | BRJZSK0 |
| 0.12% | HROW | HARROW INC | -- | $89,076.40 | 2,030 | BHNDW86 |
| 0.12% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $88,666.62 | 11,838 | 2100362 |
| 0.12% | XNCR | XENCOR INC | -- | $85,289.90 | 3,539 | BGCYWN8 |
| 0.11% | NRIX | NURIX THERAPEUTICS INC | -- | $82,455.82 | 3,686 | BMVLGP2 |
| 0.11% | NTLA | INTELLIA THERAPEUTICS INC | -- | $80,233.20 | 5,814 | BYZM6C2 |
| 0.11% | TVTX | TRAVERE THERAPEUTICS INC | -- | $79,887.50 | 4,375 | BLFGJD5 |
| 0.11% | MYGN | MYRIAD GENETICS INC | -- | $78,608.88 | 5,199 | 2614153 |
| 0.10% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $76,211.42 | 5,713 | BLB0YH0 |
| 0.10% | OCUL | OCULAR THERAPEUTIX INC | -- | $76,023.96 | 8,923 | BNZB1X8 |
| 0.10% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $75,956.40 | 4,869 | BN7Q7R7 |
| 0.10% | SPRY | ARS PHARMACEUTICALS INC | -- | $74,232.24 | 5,548 | BMCR7V2 |
| 0.10% | NVAX | NOVAVAX INC | -- | $73,622.28 | 9,157 | BJDQXG4 |
| 0.10% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $73,578.55 | 4,045 | BLB0YQ9 |
| 0.10% | ZLAB | ZAI LAB LTD-ADR | -- | $73,090.80 | 2,844 | BD9GVY0 |
| 0.10% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $71,756.14 | 8,182 | BFWLC09 |
| 0.10% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $71,049.44 | 2,212 | BLCD809 |
| 0.09% | ARDX | ARDELYX INC | -- | $68,992.00 | 13,475 | BN89V40 |
| 0.09% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $68,708.64 | 2,704 | BMFD115 |
| 0.09% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $68,495.36 | 6,689 | BKX9VD3 |
| 0.09% | INVA | INNOVIVA INC | -- | $68,234.80 | 3,580 | BDDXF67 |
| 0.09% | ANIP | ANI PHARMACEUTICALS INC | -- | $67,255.44 | 1,204 | BCDWBX6 |
| 0.09% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $66,610.32 | 5,208 | BDFKQ07 |
| 0.09% | AVDL | AVADEL PHARMACEUTICALS | -- | $64,223.28 | 5,508 | BDGMC59 |
| 0.08% | GRFS | GRIFOLS SA-ADR | -- | $59,609.20 | 6,980 | B8K7T65 |
| 0.08% | COGT | COGENT BIOSCIENCES INC | -- | $56,250.72 | 6,264 | BLR6XK8 |
| 0.08% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $56,076.04 | 1,844 | BX7RSN3 |
| 0.08% | ZYME | ZYMEWORKS INC | -- | $55,622.88 | 4,066 | BPCQZY9 |
| 0.07% | VIR | VIR BIOTECHNOLOGY INC | -- | $54,349.00 | 7,820 | BK4PZ38 |
| 0.07% | ETNB | 89BIO INC | -- | $50,791.18 | 6,061 | BK1K484 |
| 0.07% | GMAB | GENMAB A/S -SP ADR | -- | $49,128.00 | 2,400 | BBC9WC7 |
| 0.07% | KNSA | KINIKSA PHARMACEUTICALS INTE | -- | $49,034.25 | 2,325 | BRXB0C0 |
| 0.06% | EOLS | EVOLUS INC | -- | $47,087.44 | 3,611 | BDRJH21 |
| 0.06% | ABCL | ABCELLERA BIOLOGICS INC | -- | $45,867.36 | 16,863 | BL53SR3 |
| 0.06% | PCRX | PACIRA BIOSCIENCES INC | -- | $45,865.82 | 2,639 | B3X26D8 |
| 0.06% | CSTL | CASTLE BIOSCIENCES INC | -- | $45,861.44 | 1,588 | BKLCWZ3 |
| 0.06% | PLRX | PLIANT THERAPEUTICS INC | -- | $44,705.15 | 3,479 | BMDWW66 |
| 0.06% | PRTA | PROTHENA CORP PLC | -- | $44,446.32 | 3,078 | B91XRN2 |
| 0.06% | KURA | KURA ONCOLOGY INC | -- | $44,103.04 | 4,384 | BYZD465 |
| 0.06% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $43,765.04 | 4,852 | BYTYP72 |
| 0.06% | REPL | REPLIMUNE GROUP INC | -- | $43,161.30 | 3,906 | BDDVW37 |
| 0.06% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $43,052.50 | 2,125 | BKDQKM6 |
| 0.06% | ERAS | ERASCA INC | -- | $42,023.80 | 16,163 | BNLYBF3 |
| 0.06% | CGEM | CULLINAN THERAPEUTICS INC | -- | $40,558.18 | 3,319 | BM90J52 |
| 0.06% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $40,185.92 | 8,102 | BMCWKZ2 |
| 0.05% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $37,385.30 | 10,805 | BZ0QMB7 |
| 0.05% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $36,949.50 | 3,910 | BJLKVS6 |
| 0.05% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $36,878.43 | 8,439 | BJ5FZ74 |
| 0.05% | ORIC | ORIC PHARMACEUTICALS INC | -- | $36,808.32 | 4,036 | BKVDFF7 |
| 0.05% | ANAB | ANAPTYSBIO INC | -- | $36,581.76 | 1,728 | BDRW1L7 |
| 0.05% | RLAY | RELAY THERAPEUTICS INC | -- | $35,556.32 | 7,663 | BN2R582 |
| 0.05% | MLYS | MINERALYS THERAPEUTICS INC | -- | $33,770.15 | 2,845 | BP9N0G0 |
| 0.05% | TRML | TOURMALINE BIO INC | -- | $33,330.24 | 1,467 | BQ80NC6 |
| 0.05% | CVAC | CUREVAC NV | -- | $32,852.48 | 12,833 | BN4RD42 |
| 0.04% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $32,444.16 | 11,424 | BFMLGR4 |
| 0.04% | HCM | HUTCHMED CHINA-ADR | -- | $31,417.36 | 1,777 | BYXV9H7 |
| 0.04% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $30,537.62 | 9,143 | B3MZ6K5 |
| 0.04% | SVRA | SAVARA INC | -- | $30,524.04 | 9,421 | BYXGN81 |
| 0.04% | SANA | SANA BIOTECHNOLOGY INC | -- | $29,922.55 | 12,733 | BMFJJ97 |
| 0.04% | HUMA | HUMACYTE INC | -- | $29,919.78 | 6,831 | BMYTJP4 |
| 0.04% | GLPG | GALAPAGOS NV-SPON ADR | -- | $29,229.98 | 1,159 | B292NQ7 |
| 0.04% | GRAL | GRAIL INC | -- | $29,107.26 | 1,777 | BSLSSX7 |
| 0.04% | URGN | UROGEN PHARMA LTD | -- | $27,835.50 | 2,410 | BZ7PJQ1 |
| 0.04% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $27,632.88 | 1,163 | BL95N25 |
| 0.04% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $27,596.07 | 15,591 | B4N8MH9 |
| 0.04% | TBPH | THERAVANCE BIOPHARMA INC | -- | $26,908.00 | 2,800 | BMNDK09 |
| 0.04% | THRD | THIRD HARMONIC BIO INC | -- | $26,907.50 | 2,350 | BNNPQY8 |
| 0.04% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $26,407.29 | 1,547 | BKC9SX3 |
| 0.04% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $26,310.85 | 3,151 | BMGS7L1 |
| 0.04% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $26,225.60 | 4,430 | BFYQFJ2 |
| 0.04% | OABI | OMNIAB INC | -- | $26,018.30 | 6,758 | BN13S71 |
| 0.04% | RGNX | REGENXBIO INC | -- | $25,961.04 | 2,828 | BZ0G875 |
| 0.04% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $25,916.00 | 8,525 | BLR7H87 |
| 0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $25,782.12 | 3,276 | BMZ4LN0 |
| 0.04% | YMAB | Y-MABS THERAPEUTICS INC | -- | $25,744.90 | 2,549 | BG31GH0 |
| 0.04% | SIGA | SIGA TECHNOLOGIES INC | -- | $25,619.22 | 4,086 | 2107437 |
| 0.04% | TSHA | TAYSHA GENE THERAPIES INC | -- | $25,569.22 | 11,729 | BNC1BX1 |
| 0.03% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $25,252.48 | 11,968 | BFZNYB7 |
| 0.03% | SLRN | ACELYRIN INC | -- | $24,728.63 | 5,711 | BQPF874 |
| 0.03% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $23,762.26 | 2,974 | BKLXFX5 |
| 0.03% | RVNC | REVANCE THERAPEUTICS INC | -- | $23,036.16 | 5,999 | BJFSR99 |
| 0.03% | TERN | TERNS PHARMACEUTICALS INC | -- | $22,988.46 | 4,026 | BMDJ0C9 |
| 0.03% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $22,986.13 | 2,465 | BD06CS0 |
| 0.03% | VERV | VERVE THERAPEUTICS INC | -- | $22,268.60 | 4,841 | BNKGXX2 |
| 0.03% | TNGX | TANGO THERAPEUTICS INC | -- | $22,255.53 | 6,131 | BP2P6L0 |
| 0.03% | ALEC | ALECTOR INC | -- | $20,928.16 | 5,566 | BJ4LDC4 |
| 0.03% | MXCT | MAXCYTE INC | -- | $20,751.75 | 6,015 | BKMQF66 |
| 0.03% | PRME | PRIME MEDICINE INC | -- | $20,400.93 | 6,869 | BPBJFM7 |
| 0.03% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $20,225.43 | 3,897 | BPCK358 |
| 0.03% | ACIU | AC IMMUNE SA | -- | $18,604.95 | 5,655 | BZC0D70 |
| 0.02% | ACRS | ACLARIS THERAPEUTICS INC | -- | $17,642.88 | 4,084 | BYV2W40 |
| 0.02% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $17,081.26 | 7,177 | BNG1NK8 |
| 0.02% | ITOS | ITEOS THERAPEUTICS INC | -- | $16,991.70 | 2,090 | BMWXFT4 |
| 0.02% | SAGE | SAGE THERAPEUTICS INC | -- | $16,945.90 | 3,494 | BP4GNK9 |
| 0.02% | VYGR | VOYAGER THERAPEUTICS INC | -- | $16,941.60 | 3,120 | BY7RB53 |
| 0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $16,479.84 | 3,336 | B12W3P6 |
| 0.02% | QURE | UNIQURE NV | -- | $16,295.86 | 2,788 | BJFSR88 |
| 0.02% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $15,963.39 | 20,686 | BWFZX59 |
| 0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $15,691.00 | 4,828 | BLN9Z50 |
| 0.02% | PGEN | PRECIGEN INC | -- | $14,867.15 | 16,466 | BKM5C84 |
| 0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $14,598.08 | 9,604 | BN6M8F1 |
| 0.02% | LYEL | LYELL IMMUNOPHARMA INC | -- | $13,429.11 | 14,651 | BN6MB18 |
| 0.02% | BMEA | BIOMEA FUSION INC | -- | $13,193.84 | 2,068 | BNKF6N0 |
| 0.02% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $12,942.60 | 4,070 | BMQ5T49 |
| 0.02% | AMRN | AMARIN CORP PLC -ADR | -- | $12,019.69 | 22,899 | 2301938 |
| 0.02% | MGNX | MACROGENICS INC | -- | $11,523.90 | 3,590 | BFDV8K0 |
| 0.02% | EDIT | EDITAS MEDICINE INC | -- | $11,188.77 | 4,721 | BZ8FPH3 |
| 0.01% | FULC | FULCRUM THERAPEUTICS INC | -- | $10,602.90 | 3,570 | BJDX8Z9 |
| 0.01% | CRBU | CARIBOU BIOSCIENCES INC | -- | $10,240.56 | 5,172 | BNYJR68 |
| 0.01% | CHRS | COHERUS BIOSCIENCES INC | -- | $7,250.10 | 6,591 | BRK0149 |
| 0.01% | VTYX | VENTYX BIOSCIENCES INC | -- | $6,996.12 | 4,044 | BMG99Y1 |
| 0.01% | CABA | CABALETTA BIO INC | -- | $5,228.52 | 2,796 | BK5MWR1 |
| 0.01% | OVID | OVID THERAPEUTICS INC | -- | $4,304.66 | 4,061 | BYPFK63 |
| 0.01% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $3,886.77 | 3,013 | BLN7XQ1 |
| -- | BLUE | BLUEBIRD BIO INC | -- | $3,245.32 | 10,894 | BBFL7S1 |
| -- | ME | 23ANDME HOLDING CO -CLASS A | -- | $3,129.87 | 969 | BRK1ZT5 |
| -- | OKUR | ONKURE THERAPEUTICS INC-A | -- | $3,086.07 | 193 | BT7KGT6 |
| -- | RAPT | RAPT THERAPEUTICS INC | -- | $2,095.80 | 1,996 | BK5T6R0 |
| -- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
| -- | MRNS | MARINUS PHARMACEUTICALS INC | -- | $1,015.89 | 3,152 | BM8MVZ3 |
| -- | -- | TREASURY BILL | -- | $9,983,903.50 | 10,000,000 | BNNRNL0 |
| -- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $9,016,995.48 | 9,016,995 | -- |
Index
as of 9/30/2024
- Total Number of Companies214
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$7.59 billion
About the Index
The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.
Distributions
For
2024
- 2024
- 2023
- 2022
| Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
|---|
Portfolio Hedging Series
Part I: The Significance of Portfolio Hedging
Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More